遠距病人監護設備市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

2024年，全球遠距病人監護設備市場規模達170億美元，預計到2034年將以13.5%的複合年成長率成長，達到575億美元。這一快速成長主要得益於糖尿病、心血管疾病和慢性腎臟病等慢性疾病的日益流行。政府支持數位醫療的舉措以及遠距病人監護設備的廣泛應用，正在推動市場擴張。這些設備提供即時健康資料收集，從而能夠及早發現健康異常並及時干預，改善患者的預後。遠距病人監護設備種類繁多，從穿戴式感測器到手持式儀器，可追蹤各種健康指標，包括心率、血糖和血壓。

這些設備透過無線方式將資料傳輸給醫療專業人員，從而實現持續的健康監測，增強患者參與度，並支援基於價值的醫療保健模式。此外，穿戴式技術、感測器精度和人工智慧整合方面的進步，即使在發展中國家也正在提高監測解決方案的效率和客製化程度。隨著醫療保健系統借助數位化工具不斷發展，遠距醫療市場也受益於技術進步和遠距照護需求的不斷成長，持續成長。

2024年，心臟監測市場規模達40億美元，預計2034年將以13.8%的複合年成長率成長。技術進步推動了對心臟監測設備日益成長的需求，這些設備的精度和可靠性也得到了提升。這些設備能夠持續監測心率、心律和其他心臟指標等重要指標，以便在必要時快速介入。

2024 年，糖尿病領域佔了相當大的市場佔有率，達到 22.7%。持續監測血糖水平和胰島素管理等關鍵健康參數對於糖尿病護理至關重要，而 RPM 設備有助於即時追蹤、早期發現併發症並及時干預，從而防止嚴重後果和住院。

2024年，美國遠距病人監護設備市場規模達63億美元。高血壓和心血管疾病等需要持續監測的慢性疾病的盛行率不斷上升，推動了美國遠距病人監護設備市場的擴張。智慧血壓監測儀和脈搏血氧儀等遠距監護解決方案使患者和醫療保健提供者能夠即時追蹤這些病情，從而促進了市場的成長。

遠距病人監護設備產業的主要參與者包括強生、西門子醫療、美敦力、歐姆龍、VitalConnect、雅培實驗室、羅氏製藥等。這些公司透過提供先進的遠距監護解決方案來增強病人護理並改善臨床療效，在塑造行業方面發揮重要作用。為了鞏固其在遠距病人監護設備市場的地位，各公司正專注於多種策略。他們正大力投資於創新技術的研發，例如人工智慧驅動的監護系統和改進的穿戴式設備。與醫療服務提供者、醫院和遠距醫療平台建立策略合作夥伴關係正在擴大他們的影響力。各公司也致力於透過提供適合不同區域醫療需求的產品來擴大其全球影響力。此外，許多參與者正在將遠距醫療服務與遠距病人監護設備相結合，以提供更全面的護理。

目錄

第1章：方法論與範圍

第2章：執行摘要

第3章：行業洞察

• 產業生態系統分析
  • 供應商格局
  • 影響價值鏈的因素
• 產業衝擊力
  • 成長動力
    • 全球慢性病發生率上升
    • 新興國家可支配收入和醫療保健支出不斷成長
    • 已開發國家的技術進步
    • 遠距病人監護設備的普及率不斷提高
  • 產業陷阱與挑戰
    • 設備成本高
    • 嚴格的監管框架
  • 市場機會
    • 人工智慧預測監控工具的採用率不斷提高
    • 穿戴式生物感測器的出現，用於持續、即時的健康追蹤
• 成長潛力分析
• 監管格局
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲
• 技術和創新格局
  • 當前的技術趨勢
  • 新興技術
• 未來市場趨勢
• 專利分析
• 差距分析
• 波特的分析
• PESTEL分析

第4章：競爭格局

• 介紹
• 公司市佔率分析
• 公司矩陣分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 策略儀表板
• 關鍵進展
  • 併購
  • 夥伴關係與合作
  • 新產品發布
  • 擴張計劃

第5章：市場估計與預測：按產品，2021 - 2034 年

• 主要趨勢
• 心臟監測設備
• 血壓監測設備
• 神經監測設備
• 呼吸監測設備
• 多參數監測設備
• 血糖監測設備
• 胎兒及新生兒監護設備
• 睡眠監測設備
• 其他產品

第6章：市場估計與預測：按應用，2021 - 2034 年

• 主要趨勢
• 心血管疾病
• 癌症
• 糖尿病
• 神經系統疾病
• 傳染病
• 呼吸系統疾病
• 其他應用

第7章：市場估計與預測：依最終用途，2021 - 2034 年

• 主要趨勢
• 居家照護環境
• 長期照護
• 其他最終用途

第8章：市場估計與預測：按地區，2021 - 2034 年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 俄羅斯
  • 波蘭
  • 瑞士
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
  • 泰國
  • 印尼
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 哥倫比亞
  • 智利
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 以色列

第9章：公司簡介

• Abbott Laboratories
• Baxter International
• Boston Scientific
• Cerner
• DexCom
• F. Hoffmann-La Roche
• General Electric Company
• Johnson & Johnson
• Koninklijke Philips
• Medtronic
• OMRON
• Siemens Healthineers
• VitalConnect

The Global Remote Patient Monitoring Devices Market was valued at USD 17 billion in 2024 and is estimated to grow at a CAGR of 13.5% to reach USD 57.5 billion by 2034. This rapid growth is largely driven by the increasing prevalence of chronic diseases such as diabetes, cardiovascular conditions, and chronic kidney disease. Government initiatives supporting digital health and the widespread adoption of RPM devices are fueling the market expansion. These devices offer real-time health data collection, which enables early detection of health irregularities and timely interventions, improving patient outcomes. RPM devices, which range from wearable sensors to handheld instruments, track various health metrics, including heart rate, blood glucose, and blood pressure.

These devices transmit data wirelessly to healthcare professionals, allowing continuous health monitoring, enhancing patient engagement, and supporting value-based healthcare models. Furthermore, advancements in wearable technologies, sensor accuracy, and AI integration are improving the efficiency and customization of monitoring solutions, even in developing nations. As healthcare systems evolve with digital tools, the RPM market continues to grow, benefiting from technological advancements and increasing demand for remote care.

The cardiac monitoring segment generated USD 4 billion in 2024 and is expected to grow at a CAGR of 13.8% through 2034. The rising demand for cardiac monitoring devices is driven by advancements in technology, which have improved the precision and reliability of these tools. These devices allow continuous monitoring of vital metrics such as heart rate, rhythm, and other cardiac indicators, enabling rapid intervention when necessary.

The diabetes segment held a significant share of the market at 22.7% in 2024. Continuous monitoring of key health parameters, such as blood glucose levels and insulin management, is essential for diabetes care, and RPM devices facilitate real-time tracking, early detection of complications, and timely intervention, thereby preventing severe outcomes and hospitalizations.

U.S. Remote Patient Monitoring Devices Market was valued at USD 6.3 billion in 2024 The country's expansion in this sector is fueled by the rising prevalence of chronic diseases, such as hypertension and cardiovascular conditions, which require continuous monitoring. Remote monitoring solutions like smart blood pressure monitors and pulse oximeters are enabling patients and healthcare providers to track these conditions in real-time, contributing to market growth.

The key players in the Remote Patient Monitoring Devices Industry include Johnson & Johnson, Siemens Healthineers, Medtronic, OMRON, VitalConnect, Abbott Laboratories, F. Hoffmann-La Roche, and others. These companies are instrumental in shaping the industry by providing advanced remote monitoring solutions that enhance patient care and improve clinical outcomes. To strengthen their position in the RPM devices market, companies are focusing on multiple strategies. They are heavily investing in the research and development of innovative technologies such as AI-driven monitoring systems and improved wearable devices. Strategic partnerships with healthcare providers, hospitals, and telemedicine platforms are enhancing their reach. Companies are also focusing on expanding their global presence by offering products suited to different regional healthcare needs. Additionally, many players are integrating telehealth services with RPM devices to deliver more comprehensive care.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Regional
  • 2.2.2 Product
  • 2.2.3 Application
  • 2.2.4 End use
• 2.3 CXO perspectives: Strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players
• 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Supplier landscape
  • 3.1.2 Factor affecting the value chain
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising incidence of chronic diseases across the globe
    • 3.2.1.2 Growing disposable income and healthcare expenditure in emerging countries
    • 3.2.1.3 Technological advancement in developed nations
    • 3.2.1.4 Growing adoption of remote patient monitoring devices
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of devices
    • 3.2.2.2 Stringent regulatory framework
  • 3.2.3 Market opportunities
    • 3.2.3.1 Increasing adoption of AI-powered predictive monitoring tools
    • 3.2.3.2 Emergence of wearable biosensors for continuous, real-time health tracking
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 Middle East & Africa
• 3.5 Technology and innovation landscape
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Future market trends
• 3.7 Patent analysis
• 3.8 Gap analysis
• 3.9 Porter's analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard
• 4.7 Key developments
  • 4.7.1 Mergers & acquisitions
  • 4.7.2 Partnerships & collaborations
  • 4.7.3 New product launches
  • 4.7.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Cardiac monitoring devices
• 5.3 Blood pressure monitoring devices
• 5.4 Neurological monitoring devices
• 5.5 Respiratory monitoring devices
• 5.6 Multiparameter monitoring devices
• 5.7 Blood glucose monitoring devices
• 5.8 Fetal and neonatal monitoring devices
• 5.9 Sleep monitoring devices
• 5.10 Other products

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Cardiovascular diseases
• 6.3 Cancer
• 6.4 Diabetes
• 6.5 Neurological disorders
• 6.6 Infectious diseases
• 6.7 Respiratory diseases
• 6.8 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Home-care settings
• 7.3 Long-term care
• 7.4 Other end use

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Russia
  • 8.3.7 Poland
  • 8.3.8 Switzerland
  • 8.3.9 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Thailand
  • 8.4.7 Indonesia
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Colombia
  • 8.5.5 Chile
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Israel

Chapter 9 Company Profiles

• 9.1 Abbott Laboratories
• 9.2 Baxter International
• 9.3 Boston Scientific
• 9.4 Cerner
• 9.5 DexCom
• 9.6 F. Hoffmann-La Roche
• 9.7 General Electric Company
• 9.8 Johnson & Johnson
• 9.9 Koninklijke Philips
• 9.10 Medtronic
• 9.11 OMRON
• 9.12 Siemens Healthineers
• 9.13 VitalConnect